164 related articles for article (PubMed ID: 3444379)
1. Antitumor activity of synthetic alkylphospholipids with or without PAF activity.
Kudo I; Nojima S; Chang HW; Yanoshita R; Hayashi H; Kondo E; Nomura H; Inoue K
Lipids; 1987 Nov; 22(11):862-7. PubMed ID: 3444379
[TBL] [Abstract][Full Text] [Related]
2. Synthesis and antitumor activity of new amphiphilic alkylglycerolipids substituted with a polar head group, 2-(2-trimethylammonioethoxy)ethyl or a congeneric oligo(ethyleneoxy)ethyl group.
Ukawa K; Imamiya E; Yamamoto H; Aono T; Kozai Y; Okutani T; Nomura H; Honma Y; Hozumi M; Kudo I
Chem Pharm Bull (Tokyo); 1989 Dec; 37(12):3277-85. PubMed ID: 2632072
[TBL] [Abstract][Full Text] [Related]
3. Cytotoxic effects of ether lipids and derivatives in human nonneoplastic bone marrow cells and leukemic cells in vitro.
Schick HD; Berdel WE; Fromm M; Fink U; Jehn U; Ulm K; Reichert A; Eibl H; Unger C; Rastetter J
Lipids; 1987 Nov; 22(11):904-10. PubMed ID: 3444383
[TBL] [Abstract][Full Text] [Related]
4. Ether phospholipids as inhibitors of the arachidonoyl-CoA: 1-acyl-sn-glycero-3-phosphocholine acyltransferase in macrophages.
Herrmann DB; Ferber E; Munder PG
Biochim Biophys Acta; 1986 Mar; 876(1):28-35. PubMed ID: 3947667
[TBL] [Abstract][Full Text] [Related]
5. Structure-cytotoxicity studies on alkyl lysophospholipids and some analogs in leukemic blasts of human origin in vitro.
Danhauser S; Berdel WE; Schick HD; Fromm M; Reichert A; Fink U; Busch R; Eibl H; Rastetter J
Lipids; 1987 Nov; 22(11):911-5. PubMed ID: 3444384
[TBL] [Abstract][Full Text] [Related]
6. Stereospecific synthesis of antitumor active thioether PAF analogs.
Bhatia SK; Hajdu J
Lipids; 1991 Dec; 26(12):1424-30. PubMed ID: 1819745
[TBL] [Abstract][Full Text] [Related]
7. Multiparametric flow cytometry of the modulation of tumor cell membrane permeability by developmental antitumor ether lipid SRI 62-834 in EMT6 mouse mammary tumor and HL-60 human promyelocytic leukemia cells.
Dive C; Watson JV; Workman P
Cancer Res; 1991 Feb; 51(3):799-806. PubMed ID: 1988120
[TBL] [Abstract][Full Text] [Related]
8. The degradation of platelet-activating factor and related lipids: susceptibility to phospholipases C and D.
Wilcox RW; Wykle RL; Schmitt JD; Daniel LW
Lipids; 1987 Nov; 22(11):800-7. PubMed ID: 3444369
[TBL] [Abstract][Full Text] [Related]
9. Synthesis and antitumor activity of new alkylphospholipids containing modifications of the phosphocholine moiety.
Ukawa K; Imamiya E; Yamamoto H; Mizuno K; Tasaka A; Terashita Z; Okutani T; Nomura H; Kasukabe T; Hozumi M
Chem Pharm Bull (Tokyo); 1989 May; 37(5):1249-55. PubMed ID: 2630090
[TBL] [Abstract][Full Text] [Related]
10. Platelet-activating factor (PAF) antagonist WEB 2086 does not modulate the cytotoxicity of PAF or antitumour alkyl lysophospholipids ET-18-O-methyl and SRI 62-834 in HL-60 promyelocytic leukaemia cells.
Workman P; Donaldson J; Lohmeyer M
Biochem Pharmacol; 1991 Jan; 41(2):319-22. PubMed ID: 1989642
[No Abstract] [Full Text] [Related]
11. A Penicillium sp. F33 metabolite and its synthetic derivatives inhibit acetyl-CoA:1-O-alkyl-sn-glycero-3-phosphocholine acetyltransferase (a key enzyme in platelet-activating factor biosynthesis) and carrageenan-induced paw edema in mice.
Yamazaki Y; Yasuda K; Matsuyama T; Ishihara T; Higa R; Sawairi T; Yamaguchi M; Egi M; Akai S; Miyase T; Ikari A; Miwa M; Sugatani J
Biochem Pharmacol; 2013 Sep; 86(5):632-44. PubMed ID: 23817078
[TBL] [Abstract][Full Text] [Related]
12. Activation of guinea pig peritoneal macrophages by platelet activating factor (PAF) and its agonists.
Hayashi H; Kudo I; Inoue K; Onozaki K; Tsushima S; Nomura H; Nojima S
J Biochem; 1985 Jun; 97(6):1737-45. PubMed ID: 2993272
[TBL] [Abstract][Full Text] [Related]
13. Effect of synthetic phospholipids on platelet aggregation and serotonin release.
Söling U; Eibl H; Nagel GA; Unger C
Lipids; 1987 Nov; 22(11):868-70. PubMed ID: 3444380
[TBL] [Abstract][Full Text] [Related]
14. Undifferentiated HL-60 cells internalize an antitumor alkyl ether phospholipid more rapidly than resistant K562 cells.
Tsutsumi T; Tokumura A; Kitazawa S
Biochim Biophys Acta; 1998 Feb; 1390(1):73-84. PubMed ID: 9487142
[TBL] [Abstract][Full Text] [Related]
15. Impact of alkylphospholipids on the gene expression profile of HaCaT cells.
Semini G; Klein A; Danker K
Pharmacogenet Genomics; 2011 Jul; 21(7):375-87. PubMed ID: 21681147
[TBL] [Abstract][Full Text] [Related]
16. Synthesis of 1-O-alkyl-2-O-methyl-glycerophospholipids with potential antitumor activity.
Alunni-Bistocchi G; Orvietani PL; Ricci A; Binaglia L; Orlando M; Orlando P
Farmaco; 1990 May; 45(5):499-509. PubMed ID: 2222722
[TBL] [Abstract][Full Text] [Related]
17. Growth arrest vs direct cytotoxicity and the importance of molecular structure for the in vitro anti-tumour activity of ether lipids.
Lohmeyer M; Workman P
Br J Cancer; 1995 Aug; 72(2):277-86. PubMed ID: 7640206
[TBL] [Abstract][Full Text] [Related]
18. Isosteric phosphonate analogs of ET-16-OMe. Synthesis and biological evaluation of the enantiomers of 2'-(trimethylammonio)ethyl 4-(hexadecyloxy)-3-methoxybutanephosphonate and 2'-(trimethylammonio)ethyl 4-(hexadecylthio)-3-methoxybutanephosphonate.
Bittman R; Byun HS; Mercier B; Salari H
J Med Chem; 1994 Feb; 37(3):425-30. PubMed ID: 8308870
[TBL] [Abstract][Full Text] [Related]
19. Synthesis of sulfur analogues of alkyl lysophospholipid and neoplastic cell growth inhibitory properties.
Morris-Natschke S; Surles JR; Daniel LW; Berens ME; Modest EJ; Piantadosi C
J Med Chem; 1986 Oct; 29(10):2114-7. PubMed ID: 3761326
[TBL] [Abstract][Full Text] [Related]
20. Antitumor activity of SRI 62-834, a cyclic ether analog of ET-18-OCH3.
Houlihan WJ; Lee ML; Munder PG; Nemecek GM; Handley DA; Winslow CM; Happy J; Jaeggi C
Lipids; 1987 Nov; 22(11):884-90. PubMed ID: 2832680
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
